Colan Totte.Co.,Ltd. (7792) Stock Price

Colantotte is a company primarily engaged in developing and selling magnetic therapy devices using permanent magnets for home use. The company offers products designed to improve blood circulation in the area where they are worn and alleviate stiffness. While outsourcing manufacturing, Colantotte obtains medical device certifications and safety standards both domestically and internationally.

The company's main customers are individual consumers, with revenue generated through three sales channels: wholesale, e-commerce, and direct retail stores. Wholesale primarily serves domestic and international sales agents and retailers, e-commerce includes the company's own website and online malls, and retail centers on 18 directly operated stores in Japan. The Colantotte business is the primary revenue driver, while the CSS business, which provides emergency contact services, is still in the member acquisition phase and currently represents a small portion of overall revenue.

The company maintains a broad product lineup, including necklaces for the neck and shoulders, loops for the arms, and wear and supports for the lower back, back, knees, and elbows. RESNO, launched in 2019, has been strengthened with a product line for sleep environments, including recovery wear and magnetic pillows. In 2022, the company launched "Lierrey," a brand for women, to expand its women's product offerings. Additionally, in the life security segment, Colantotte provides emergency contact services for members and is working to expand its membership base.

The company is pursuing sustainable growth by prioritizing two key strategic initiatives: "building brand market recognition" and "establishing multiple revenue streams." The company manages three primary performance metrics: revenue growth rate, operating profit margin on sales, and e-commerce (EC) sales composition ratio. By increasing the EC sales ratio, the company aims to reduce risk concentration in wholesale channels while improving gross margins. The company operates 18 directly managed stores domestically and distributes through sales agents in 7 countries internationally, combining these channels to expand customer acquisition and build repeat customer loyalty.

Priority investment areas include branding, product development, and marketing personnel expansion in the health accessories sector. The company differentiates itself by emphasizing design quality under the concept of "display and appeal," positioning the Colantotte brand as its core competitive advantage. Specific initiatives include design improvements, intellectual property protection, rigorous quality control, and measures to enhance perceived quality through athlete endorsements and medical device certifications.

For new market development, the company plans to expand its product lineup with offerings such as RESNO in the sleep category (launched 2019, repositioned as a sleep brand in 2023) and Lierrey, a women-focused brand (launched 2022), to capture emerging demand. In the life security segment, the company is growing CSS, a membership-based emergency contact service, targeting stable recurring revenue through a subscription model. As demand increases for support services addressing elderly individuals living alone and emergency risks outside the home, the company is advancing concrete partnerships, including dedicated service offerings through Meiji Yasuda Life Insurance.

On the technology front, the company is developing new materials and product forms—including recovery wear for sleep improvement and magnetic pillows—while building on its core permanent magnet-based blood circulation improvement technology. Manufacturing is outsourced while prioritizing medical device safety standards and certifications, with resources allocated to substantiate product efficacy and ensure quality assurance. Additionally, the company continues efforts to increase customer lifetime value through enhanced marketing PDCA cycles and improved service offerings leveraging member data.